Fortress Biotech (FBIO) Current Assets (2010 - 2026)

Fortress Biotech's Current Assets history runs 16 years deep, the most recent figure standing at $123.8 million for Q4 2025.

• In Q4 2025, Current Assets rose 37.04% year-over-year to $123.8 million; the TTM figure through Dec 2025 stood at $123.8 million (up 37.04% YoY), while the FY2025 annual figure was $123.8 million, up 37.04% from the prior year.
• Current Assets for Q4 2025 stood at $123.8 million, up from $118.5 million in the prior quarter.
• The five-year high for Current Assets was $346.5 million in Q4 2021, with the low at $86.3 million in Q3 2024.
• The 5-year median for Current Assets is $127.3 million (2023), against an average of $191.8 million.
• The sharpest annual moves came in 2021 and 2023: Current Assets soared 100.25% in 2021, then plunged 62.08% in 2023.
• Fortress Biotech's Current Assets stood at $346.5 million in 2021, then slumped by 33.49% to $230.4 million in 2022, then tumbled by 49.22% to $117.0 million in 2023, then retreated by 22.77% to $90.4 million in 2024, then surged by 37.04% to $123.8 million in 2025.
• Business Quant data shows FBIO's Current Assets at $123.8 million in Q4 2025, $118.5 million in Q3 2025, and $110.4 million in Q2 2025.